How brain stimulation affects learning of speech sounds in Parkinson's disease and essential tremor
Studies how deep brain stimulation affects speech learning in Parkinson's disease and essential tremor.
Key facts
- Who runs it
- Boston University Charles River Campus
- Where
- Boston, United StatesSee the 2 sites
- Trial code
- Registry title
- Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 18 Feb 2026
- Expected to end
- Aug 2030
- Type of study
- Interventional, 4 groups
- Treatments tested
- Phoneme sequence learning
- Cessation and re-enabling of stimulation of the STN
- Cessation and re-enabling of stimulation of the VIM thalamic nucleus
- Multisyllabic sequence learning
- Record updated
- 9 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease or essential tremor who already have a deep brain stimulation (DBS) device. They will do speech learning tasks.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- A clinically established diagnosis of Parkinson's disease (device in the subthalamic nucleus) or essential tremor (device in the ventral intermediate nucleus of the thalamus)
- Earlier treatment
- Must already be treated with deep brain stimulation. Medication and DBS settings must have been stable for at least one month.
- Biomarker or test result
- For recording brain activity, a Medtronic Percept PC or Percept RC implantable pulse generator.
Main reasons for not taking part
- Cognitive impairment (MoCA score under 25) or active psychotic or behavioral symptoms
- Hearing impairment that interferes with the speech task
- Aphasia or dysarthria that prevents doing the speech task
- Cannot tolerate symptoms when DBS is off
- Pregnancy
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Native speakers of American English
- Adults at least 18 years of age
- A clinically established diagnosis of Parkinson's disease or essential tremor
- Able to provide informed consent in the judgment of the investigator
- Treated with deep brain stimulation of the subthalamic nucleus (Parkinson's disease) or ventral intermediate nucleus of the thalamus (essential tremor)
- Stable Parkinson's disease or essential tremor medication regimen for at least one month
- Stable DBS program settings for at least one month
- Nominal DBS system function, including normal impedances at therapeutic DBS contacts, and adequate battery life or adequate IPG charging status for therapy
- For DBS sensing, implanted with Medtronic Percept PC or Percept RC implantable pulse generator
- Corrected vision adequate to easily read text presented during speech motor task
Who cannot take part
- Cognitive impairment (Montreal Cognitive Assessment (MoCA; Nesreddine et al., 2005) score < 25) or active psychotic or behavioral symptoms that would, in the judgment of the investigator, preclude proper participation in the study
- Hearing impairment that interferes with accurate perception of the speech motor learning stimulus (25dB hearing level threshold at 500, 1k, 2k, and 4kHz frequencies)
- Language impairment (aphasia) or speech articulation impairment (dysarthria) that precludes performance of the speech motor learning task
- Neurological disorder that interferes with speech motor learning
- Inability to tolerate symptoms when DBS is off
- Orthodontia or atypical oral structure (e.g., cleft palate) that interferes with speech
- Pregnancy
- For participants in the sub-syllabic sequence learning study (Study C.2.1), experience with the following languages: Hebrew, Polish, Lithuanian, Romanian, Georgian, Tepehua, Hungarian, and Pima
Where in United States
- Boston UniversityBoston, United StatesContact: Frank H Guenther, Ph.D.Taking people
- Massachusetts General HospitalBoston, United StatesContact: Todd Herrington, MD, PHDTaking people
About the trial
What the trial wants to find out
This study will examine how two important brain circuits - one involving the subthalamic nucleus (STN) and one involving the ventral intermediate nucleus of the thalamus (VIM) - contribute to learning and producing speech sequences. Participants will include two groups: 1. individuals with Parkinson's disease who have deep brain stimulation (DBS) devices targeting the STN and 2. individuals with essential tremor who have DBS devices targeting the VIM.
Read full original descriptionShow less
Participants will complete speech tasks involving the learning and repetition of novel sound sequences. During some parts of the study, DBS stimulation will be temporarily turned on or off in a controlled research setting. This will allow researchers to examine how stimulation affects both the learning of new speech sequences and the production of previously learned sequences. All STN participants and most VIM participants will also be equipped with a cutting-edge DBS system, the Percept PC, which will enable the recording of deep brain activity during the tasks.
The results of this study will improve our understanding of how different brain circuits support speech learning and production. In particular, this study will help to differentiate the roles of the STN and VIM in learning the ordering of speech sounds within a syllable from learning of speech sequences containing multiple syllables. This knowledge may help guide future approaches to optimizing DBS settings to improve both movement and speech outcomes in individuals with neurological disorders, as well as provide greater general insight into how these brain structures contribute to speech production and learning.
The 4 groups in the trial
- Subthalamic nucleus with subsyllabic learning armTreatment being tested
Arm 1: subjects with implanted STN deep brain stimulators will undergo learning tasks involving non-English sound sequences while their stimulators are turned on and off
Treatment: Phoneme sequence learning and Cessation and re-enabling of stimulation of the STN
- Subthalamic nucleus with multisyllabic learning armTreatment being tested
Arm 2: subjects with implanted STN deep brain stimulators will undergo learning tasks involving syllable sequences while their stimulators are turned on and off
Treatment: Cessation and re-enabling of stimulation of the STN and Multisyllabic sequence learning
- Ventral intermediate thalamus with subsyllabic learning armTreatment being tested
Arm 3: subjects with implanted VIM deep brain stimulators will undergo learning tasks involving non-English sound sequences while their stimulators are turned on and off
Treatment: Phoneme sequence learning and Cessation and re-enabling of stimulation of the VIM thalamic nucleus
- Ventral intermediate thalamus with multisyllabic learning armTreatment being tested
Arm 4: subjects with implanted VIM deep brain stimulators will undergo learning tasks involving syllable sequences while their stimulators are turned on and off
Treatment: Cessation and re-enabling of stimulation of the VIM thalamic nucleus and Multisyllabic sequence learning
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
- Plain-language title
- How brain stimulation affects learning of speech sounds in Parkinson's disease and essential tremorGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 9 March 2026